{
 "name": "宣捷幹細胞",
 "slug": "tw-4724",
 "aliases": [
  "宣捷幹細胞生技股份有限公司",
  "MERIBANKBIOTECH",
  "4724"
 ],
 "ticker": "4724",
 "industry": "生技醫療業",
 "website": "http://www.meribank.com.tw",
 "summary": "宣捷幹細胞（4724）是興櫃的生技醫療類股公司，2001 年成立，2023 年登錄興櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "宣捷幹細胞生技股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "英文簡稱",
   "value": "MERIBANKBIOTECH",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心興櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "登錄興櫃日期",
   "value": "2023-06-16",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "成立日期",
   "value": "2001-02-13",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "董事長",
   "value": "宣昶有",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "總經理",
   "value": "蔡建芳",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "實收資本額",
   "value": 959764060,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "資誠聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "公司網址",
   "value": "http://www.meribank.com.tw",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "主要產品：臍帶血與胎盤/臍帶間質幹細胞儲存",
   "value": "新生兒幹細胞分離與儲存服務",
   "unit": "",
   "as_of": "2026-03-20",
   "source": "https://www.meribank.com.tw/upload/investor_document_files/twL_investor_document_26G07_yqbYVL4xny.pdf",
   "note": "114年度年報紙本第49至50頁。"
  },
  {
   "claim": "主要產品：成人免疫細胞儲存",
   "value": "成人血液分離、分管儲存與培養擴增技術",
   "unit": "",
   "as_of": "2026-03-20",
   "source": "https://www.meribank.com.tw/upload/investor_document_files/twL_investor_document_26G07_yqbYVL4xny.pdf",
   "note": "114年度年報紙本第49至50頁。"
  },
  {
   "claim": "主要產品：GMP規格細胞",
   "value": "GMP規格細胞銷售",
   "unit": "",
   "as_of": "2026-03-20",
   "source": "https://www.meribank.com.tw/upload/investor_document_files/twL_investor_document_26G07_yqbYVL4xny.pdf",
   "note": "114年度年報紙本第49至50頁。"
  },
  {
   "claim": "主要產品：幹細胞外泌體",
   "value": "外泌體開發、客製化服務與周邊商品",
   "unit": "",
   "as_of": "2026-03-20",
   "source": "https://www.meribank.com.tw/upload/investor_document_files/twL_investor_document_26G07_yqbYVL4xny.pdf",
   "note": "114年度年報紙本第49至50頁。"
  },
  {
   "claim": "管線：UMC119-06-05（異體臍帶間質幹細胞）",
   "value": "慢性阻塞性肺病（COPD）｜臨床二期；登錄招募中｜台灣",
   "unit": "",
   "as_of": "2024-07-08",
   "source": "https://clinicaltrials.gov/api/v2/studies/NCT06491043",
   "note": "NCT06491043；as_of為Last Update Posted，非本次查閱日。 登錄自2024未更新，非核對日招募狀態再確認；公司最新外銷專用許可不等於試驗完成或台灣內銷核准。"
  },
  {
   "claim": "管線：UMC119-06-05（異體臍帶間質幹細胞；衰弱症）",
   "value": "老年衰弱症｜臨床一/二期；登錄進行中、不招募｜台灣",
   "unit": "",
   "as_of": "2024-07-15",
   "source": "https://clinicaltrials.gov/api/v2/studies/NCT06501066",
   "note": "NCT06501066；as_of為Last Update Posted，非本次查閱日。 登錄自2024未更新，非核對日招募狀態再確認；公司最新外銷專用許可不等於試驗完成或台灣內銷核准。"
  },
  {
   "claim": "催化劑：UMC119-06-05（COPD）",
   "value": "試驗預估完成｜2027-12-30（試驗登錄預估）｜已公告",
   "unit": "",
   "as_of": "2024-07-08",
   "source": "https://clinicaltrials.gov/api/v2/studies/NCT06491043",
   "note": "NCT06491043；日期精度照登錄，並非主管機關審查目標日；預估日期仍可能調整。 登錄自2024未更新，非核對日招募狀態再確認；公司最新外銷專用許可不等於試驗完成或台灣內銷核准。"
  },
  {
   "claim": "催化劑：UMC119-06-05（衰弱症）",
   "value": "試驗預估主要完成｜2026-12（試驗登錄預估）｜已公告",
   "unit": "",
   "as_of": "2024-07-15",
   "source": "https://clinicaltrials.gov/api/v2/studies/NCT06501066",
   "note": "NCT06501066；日期精度照登錄，並非主管機關審查目標日；預估日期仍可能調整。 登錄自2024未更新，非核對日招募狀態再確認；公司最新外銷專用許可不等於試驗完成或台灣內銷核准。"
  },
  {
   "claim": "催化劑：UMC119-06-05（衰弱症）",
   "value": "試驗預估完成｜2027-12（試驗登錄預估）｜已公告",
   "unit": "",
   "as_of": "2024-07-15",
   "source": "https://clinicaltrials.gov/api/v2/studies/NCT06501066",
   "note": "NCT06501066；日期精度照登錄，並非主管機關審查目標日；預估日期仍可能調整。 登錄自2024未更新，非核對日招募狀態再確認；公司最新外銷專用許可不等於試驗完成或台灣內銷核准。"
  },
  {
   "claim": "管線：麥力優（Meriyouth）",
   "value": "慢性阻塞性肺病（COPD）｜取得TFDA外銷專用藥品許可證｜台灣（外銷專用）",
   "unit": "",
   "as_of": "2026-10-01",
   "source": "https://mops.twse.com.tw/mops/#/web/t05st01",
   "note": "公司4724；年度115；發言日期2026-10-01 17:48:31；序號2；主旨：公告本公司開發之異體臍帶間質幹細胞治療慢性阻塞性肺病製劑產品麥力優取得衛福部核發外銷專用藥品許可證。許可證衛部菌疫製字第000163號；10/1為公告收函日，未以此當發證日；外銷專用不等同台灣內銷或外國上市核准。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-22",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-4724.json",
 "generated_at": "2026-10-23T11:48:56.615Z"
}